ASSTON PHARMACEUTI...● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO ASSTON PHARMACEUTI...● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO
Live GMP
Back to IPOs
Asston Pharmaceuticals Ltd.

Asston Pharmaceuticals Ltd.

BSE SME · SME IPO
Listed BSE SME SME Live Chart
Issue Price
₹123
₹123
GMP (Grey Market)
NIL
Unofficial data only
Est. Listing Price
₹123
Based on GMP
Min. Investment
₹123,000
1 lot × 1000 shares
Subscribed
1.00x
Over-subscribed
IPO Details
Open Date
09 Jul 2025
Close Date
11 Jul 2025
Allotment
14 Jul 2025
Listing Date
16 Jul 2025
Exchange
BSE SME
Price Band
₹123
Listing Price
See chart
Allotment Status
Price Band
₹123
Per share
Face Value
₹10 per share
 
Lot Size
1,000 Shares
per lot
Issue Size
22,41,000 shares (aggregating up to ₹27.56 Cr)
Total offering
Issue Type
Bookbuilding IPO
 
Min Investment
₹123,000
1 lot
Pre-IPO Holding
62,71,360 shares
Promoters
Post-IPO Holding
85,12,360 shares
Promoters
P/E (Pre)
17.83x
 
P/E (Post)
13.2x
 
EPS (Pre)
₹6.90
 
EPS (Post)
₹9.32
 
UPI Deadline
2025-07-11
Mandate
Anchor AllotmentTue, 08 Jul 2025
Basis of AllotmentMon, 14 Jul 2025
Refund InitiationTue, 15 Jul 2025
Demat CreditTue, 15 Jul 2025
Listing DayWed, 16 Jul 2025
UPI Mandate Deadline2025-07-11
Sale TypeFresh Capital
Net Offer to Public21,28,000 shares (aggregating up to ₹26.17 Cr)
Market Maker Quota1,13,000 shares (aggregating up to ₹1.39 Cr)
QIB Quota50% of Net Issue
HNI / NII Quota15% of Net Issue
Retail Quota35% of Net Issue
Check AllotmentClick here →
Subscription Rate Final
Asston Pharmaceuticals Ltd. IPO subscribed 1.00 times overall. Retail: 1.00x. QIB: 1.00x. NII: 1.00x. By 11 Jul 2025.
QIB
1.00x
Over
NII/HNI
1.00x
Over
Retail
1.00x
Over
Total
1.00x
Over
Category Subscription Shares Offered % of Total Amount (₹Cr)
Market Maker
Awaited
113,000
₹1.39
QIB
Over 1.00x
NII / HNI
Over 1.00x
Retail
Over 1.00x
Total 1.00x
2,241,000
100% ₹27.56
IPO Shares Offered
Asston Pharmaceuticals Ltd. IPO total issue size: ₹27.56 Cr.
CategoryShares OfferedAmount (₹Cr)Size (%)
Market Maker 113,000 ₹1.39
5.04%
Total 2,241,000 ₹27.56
100.00%
* Based on upper price band ₹123 per share
Lot Size & Investment
Lot Size
1,000
Shares per Lot
Issue Price
₹123.00
Upper Band
Min Investment
₹123,000
1 Lot
ApplicationLotsSharesAmount
Retail (Min — 2 Lots)22,000₹246,000
Retail (Max — 13 Lots)1313,000₹1,599,000
S-HNI (Min — 14 Lots)1414,000₹1,722,000
B-HNI (Min — 68 Lots)6868,000₹8,364,000
* Issue Price ₹123 × Lot Size 1,000 shares
IPO Schedule
Anchor
08 Jul 2025
✓ Done
IPO Open
09 Jul 2025
✓ Done
IPO Close
11 Jul 2025
✓ Done
Allotment
14 Jul 2025
✓ Done
Refunds
15 Jul 2025
✓ Done
Demat Credit
15 Jul 2025
✓ Done
Listing Day
16 Jul 2025
✓ Done
Asston Pharmaceuticals Ltd. — Live Price LIVE
₹123.00
INR · BSE
Fetching…
vs Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading…
Chart Not Available
Try again 2–3 days after listing.
Issue ₹123.00 Live Price
About Asston Pharmaceuticals Ltd.
Incorporated in 2019, Asston Pharmaceuticals Limited is engaged in the business of pharmaceuticals, specializing in exporting healthcare products globally.The company offers a diverse range of products, including tablets, capsules, sachets, and syrups. Its product portfolio encompasses various therapeutic categories, such as analgesics, antibiotics, antifungals, vitamins, and more.The company manufactures pharmaceutical products for direct sales and also on a contract manufacturing or loan license basis, primarily working on a principle-to-principle approach with various marketers.The company is FDA certified by both Central and State FDA, accredited by NQA (Nuclear Quality Assurance), and complies with Quality Management System (QMS) standards, ensuring high-quality manufacturing.Products:Albendazole USP 400 mg: Albendazole USP 400 mg refers to a higher dosage of Albendazole, a broad-spectrum anthelmintic (anti-worm) medication that is used to treat various parasitic worm infections.Diclofenac 100 mg: Diclofenac 100 mg refers to a specific dosage of Diclofenac, a widely used nonsteroidal anti-inflammatory drug (NSAID).Ibuprofen, paracetamol: Ibuprofen and Paracetamol (Acetaminophen) are two commonly used over-the-counter medications, often used to relieve pain and reduce fever.Ferrovit Syrup: To treat vitamin and mineral deficiencies.As of 3 July 2025, the company has 46 Permanent employees and 6 contractual employees in various departments.Competitive Strengths:Formulation ExpertiseExperienced PromotersWide range of ProductsStrategic LocationSkilled Workforce
Objects of the Issue
1
1 Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit
2
2 Funding the incremental working capital requirements of the Company
3
3 Repayment and/or prepayment, in part or full, of certain of the outstanding borrowings availed by the Company
4
4 General Corporate Purposes
Asston Pharmaceuticals Ltd. Financials (Amount In Crore)
Revenue from Operations
₹15.8
31 Mar 2024
₹25.6
31 Mar 2025
₹6.2
31 May 2025
Profit After Tax (PAT)
₹1.4
31 Mar 2024
₹4.3
31 Mar 2025
₹1.3
31 May 2025
Particulars31 May 202531 Mar 202531 Mar 2024
Revenue from Operations 6.21 25.61 15.84
EBITDA 1.93 6.16 2.55
Profit After Tax (PAT) 1.32 4.33 1.36
Net Worth 12.04 10.72 6.39
Total Assets 31.83 28.12 20.26
Reserves & Surplus 5.77 4.45 5.61
Borrowings 7.83 7.26 6.82
EBITDA Margin (%) 24.60%
PAT Margin (%) 17.27%
P/BV Ratio
12.07
RoE
50.56%
RoCE
51.25%
RoNW
40.36%
PAT Margin
17.27%
EBITDA Margin
24.60%
Debt/Equity
0.68
Issue Structure & Shareholding
Total Shares Offered22,41,000 (100.00%)
Net Offer to Public21,28,000 shares (aggregating up to ₹26.17 Cr)
Reserved for Market Maker1,13,000 shares (aggregating up to ₹1.39 Cr)
Pre-Issue Promoter Holding62,71,360 shares
Post-Issue Promoter Holding85,12,360 shares
P/BV Ratio12.07
RoE50.56%
RoCE51.25%
Debt / Equity0.68
Script CodeN/A
Registrar & Lead Managers
Book Running Lead Managers
Sobhagya Capital Options Pvt.Ltd.
GMP Disclaimer: Grey Market Premium data is unofficial and unregulated. It does not guarantee actual listing price.
IPO Subscription FAQs
How much Asston Pharmaceuticals Ltd. IPO subscribed?

Asston Pharmaceuticals Ltd. IPO is subscribed 1.00 times by Jul 11, 2025. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.

Investor CategorySubscription
Qualified Institutional (QIB)1.00x
Non Institutional (NII/HNI)1.00x
Retail Individual1.00x
Total Subscription1.00x
What is Asston Pharmaceuticals Ltd. IPO retail subscription status?

The Asston Pharmaceuticals Ltd. IPO retail category is subscribed 1.00 times as of 11 Jul 2025. The retail portion is oversubscribed.

How to subscribe Asston Pharmaceuticals Ltd. IPO?

Subscribe via your broker app using ASBA or UPI. Opens 09 Jul 2025 and closes 11 Jul 2025. Min investment: ₹123,000 (1 lot = 1,000 shares). UPI mandate: 2025-07-11.

How many times Asston Pharmaceuticals Ltd. IPO subscribed?

The Asston Pharmaceuticals Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.

How to check Asston Pharmaceuticals Ltd. IPO allotment?

Check allotment on the registrar website (Maashitla Securities Pvt.Ltd.) at https://maashitla.com/allotment-status/public-issues. Enter your PAN, application number or DP/Client ID. Allotment date: 14 Jul 2025. Refunds: on 15 Jul 2025.

When Asston Pharmaceuticals Ltd. IPO will be listed?

The Asston Pharmaceuticals Ltd. IPO listing date is 16 Jul 2025, Wednesday. Listed on: BSE SME. Issue price: ₹123. Estimated listing: ₹123. GMP: NIL.

When Asston Pharmaceuticals Ltd. IPO close?

The Asston Pharmaceuticals Ltd. IPO closes on 11 Jul 2025, Friday. UPI mandate: 2025-07-11. Allotment: 14 Jul 2025. Listing: 16 Jul 2025.